ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
IceCure Medical Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 17, 2026
$1.08+0.02 (+1.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.1
- Dividend yield
- –
IceCure Medical Ltd. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 36.3%
- Operating margin
- -446.7%
- Net margin
- -445.6%
- Return on equity, FY2025
- -188.8%
Financial strength
- Current ratio
- 2.87
- Debt to equity
- 0.00
- Debt to assets
- 0.1%
- Cash to current liabilities
- 207.8%
Valuation
- P/E ratio
- 0.1
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –